Signe Risum

925 total citations
22 papers, 635 citations indexed

About

Signe Risum is a scholar working on Surgery, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Signe Risum has authored 22 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Reproductive Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Signe Risum's work include Ovarian cancer diagnosis and treatment (9 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Signe Risum is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Signe Risum collaborates with scholars based in Denmark, United States and Sweden. Signe Risum's co-authors include Estrid Høgdall, Claus Høgdall, Lotte Nedergaard, Lene Lundvall, Anne Kiil Berthelsen, Annika Loft, Svend Aage Engelholm, Silke Engelholm, Seppo W. Langer and Svend A. Engelholm and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

Signe Risum

22 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Signe Risum Denmark	13	339	264	199	191	148	22	635
Melina Shoni United States	12	189 0.6×	127 0.5×	224 1.1×	155 0.8×	30 0.2×	23	619
M.S. Kao United States	13	212 0.6×	170 0.6×	400 2.0×	73 0.4×	49 0.3×	22	579
J. A. Lejárcegui Spain	13	351 1.0×	185 0.7×	422 2.1×	61 0.3×	30 0.2×	21	674
A. Badzio Poland	15	82 0.2×	125 0.5×	172 0.9×	169 0.9×	67 0.5×	47	620
Joerg Schwarz Germany	11	73 0.2×	166 0.6×	140 0.7×	97 0.5×	169 1.1×	13	592
René Blom Sweden	8	91 0.3×	87 0.3×	127 0.6×	416 2.2×	358 2.4×	11	644
Noriko Ii Japan	13	46 0.1×	185 0.7×	135 0.7×	200 1.0×	74 0.5×	40	519
Yu Ohkubo Japan	10	45 0.1×	141 0.5×	137 0.7×	120 0.6×	77 0.5×	25	494
Yann Delpech France	15	152 0.4×	243 0.9×	258 1.3×	75 0.4×	56 0.4×	48	738
K. Ohmi Japan	13	247 0.7×	126 0.5×	305 1.5×	88 0.5×	21 0.1×	24	535

Countries citing papers authored by Signe Risum

Since Specialization

Citations

This map shows the geographic impact of Signe Risum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Signe Risum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Signe Risum more than expected).

Fields of papers citing papers by Signe Risum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Signe Risum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Signe Risum. The network helps show where Signe Risum may publish in the future.

Co-authorship network of co-authors of Signe Risum

This figure shows the co-authorship network connecting the top 25 collaborators of Signe Risum. A scholar is included among the top collaborators of Signe Risum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Signe Risum. Signe Risum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reynolds, John V., Shaun R. Preston, Brian Patrick O’Neill, et al.. (2023). Neo-AEGIS (Neoadjuvant Trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Final primary outcome analysis.. Journal of Clinical Oncology. 41(4_suppl). 295–295. 13 indexed citations

Josipović, Mirjana, Signe Risum, Julien Jomier, et al.. (2022). Accuracy and consistency of intensity-based deformable image registration in 4DCT for tumor motion estimation in liver radiotherapy planning. PLoS ONE. 17(7). e0271064–e0271064. 7 indexed citations

Halvorsen, Tarje Onsøien, Øystein Fløtten, Odd Terje Brustugun, et al.. (2022). Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer. Lung Cancer. 166. 49–57. 2 indexed citations

Jensen, Lars Henrik, Signe Risum, Tommie Mynster, et al.. (2022). Curative chemoradiation for low rectal cancer: Primary clinical outcomes from a multicenter phase II trial.. Journal of Clinical Oncology. 40(17_suppl). LBA3514–LBA3514. 12 indexed citations

Grønberg, Bjørn Henning, Øystein Fløtten, Odd Terje Brustugun, et al.. (2021). High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. The Lancet Oncology. 22(3). 321–331. 76 indexed citations

Reynolds, John V., Shaun R. Preston, Brian O’Neill, et al.. (2021). Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (Modified MAGIC or FLOT protocol). (NCT01726452).. Journal of Clinical Oncology. 39(15_suppl). 4004–4004. 75 indexed citations

Jensen, Lars Henrik, Laurids Østergaard Poulsen, Signe Risum, et al.. (2020). 400MO Curative chemoradiation for low rectal cancer: Early clinical outcomes from a multicentre phase II trial. Annals of Oncology. 31. S411–S411. 2 indexed citations

Vogelius, Ivan R., et al.. (2020). Intrafractional fiducial marker position variations in stereotactic liver radiotherapy during voluntary deep inspiration breath-hold. British Journal of Radiology. 93(1116). 20200859–20200859. 20 indexed citations

Risum, Signe, Ulrich Knigge, & Seppo W. Langer. (2017). Hitherto unseen survival in an ALK ‐positive‐patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine. Clinical Case Reports. 5(12). 2085–2087. 2 indexed citations

10.

Risum, Signe, Annika Loft, Svend Aage Engelholm, et al.. (2012). Positron Emission Tomography/Computed Tomography Predictors of Overall Survival in Stage IIIC/IV Ovarian Cancer. International Journal of Gynecological Cancer. 22(7). 1163–1169. 23 indexed citations

11.

Høgdall, Claus, Eric T. Fung, Ib Jarle Christensen, et al.. (2011). A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer. Gynecologic Oncology. 123(2). 308–313. 21 indexed citations

12.

Petri, Anette Lykke, Anja Hviid Simonsen, Estrid Høgdall, et al.. (2010). Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis. PROTEOMICS - CLINICAL APPLICATIONS. 4(3). 304–314. 18 indexed citations

13.

Høgdall, Estrid, Eric T. Fung, Ib Jarle Christensen, et al.. (2010). Proteomic biomarkers for overall and progression‐free survival in ovarian cancer patients. PROTEOMICS - CLINICAL APPLICATIONS. 4(12). 940–952. 25 indexed citations

14.

Risum, Signe, Claus Høgdall, Annika Loft, et al.. (2009). Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?. Gynecologic Oncology. 116(3). 395–398. 52 indexed citations

15.

Risum, Signe, Estrid Høgdall, Svend A. Engelholm, et al.. (2009). A Proteomics Panel for Predicting Optimal Primary Cytoreduction in Stage III/IV Ovarian Cancer. International Journal of Gynecological Cancer. 19(9). 1535–1538. 5 indexed citations

16.

Risum, Signe, Henrik Roed, Svend A. Engelholm, et al.. (2009). Influence of 2-(18F) Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography on Recurrent Ovarian Cancer Diagnosis and on Selection of Patients for Secondary Cytoreductive Surgery. International Journal of Gynecological Cancer. 19(4). 600–604. 37 indexed citations

17.

Risum, Signe, Claus Høgdall, Annika Loft, et al.. (2007). The diagnostic value of PET/CT for primary ovarian cancer—A prospective study. Gynecologic Oncology. 105(1). 145–149. 120 indexed citations

18.

Risum, Signe, Claus Høgdall, Annika Loft, et al.. (2007). Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography—A prospective study. Gynecologic Oncology. 108(2). 265–270. 81 indexed citations

19.

Høgdall, Estrid, Eric T. Fung, Zhi Zhang, et al.. (2006). A Panel Of Seven Biomarkers Improves Specificity In Discriminating Malignant From Benign Pelvic Masses. International Journal of Gynecological Cancer. 16. 682–682. 1 indexed citations

20.

Risum, Signe & S Bülow. (2003). Doxorubicin treatment of an intra‐abdominal desmoid tumour in a patient with familial adenomatous polyposis. Colorectal Disease. 5(6). 585–586. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact